The Magnificent Seven gained more than 13% last month, making the group of big tech stocks one of the best-performing corners ...

After months of Wall Street gyrations to the twists and turns of U.S. trade policy, signs suggest stock investors are ...

Wall Street strategists are upgrading their outlook for the S&P 500 as tariffs aren't expected to weigh on corporate earnings ...

Fundstrat's head of research Tom Lee says the stock market is in the midst of a "most hated" rally, with skeptical investors ...

Higher prices and weaker US economic growth over the summer are likely to threaten the S&P 500’s rally, according to JPMorgan ...

Futures for the S&P 500 and Nasdaq 100 gained 1.6% and 2% after the ruling, which the Trump administration will appeal.

Europe’s equities have emerged clear winners worldwide as the region’s economic outlook brightens at a time when President ...

Not every strategist fears that high valuations will halt the advance. Keith Lerner, co-chief investment officer and chief ...

Pharma stocks appear to be recalibrating, while in their current phase, they are reflecting 'consolidation'. Meanwhile, ...